Literature DB >> 14592780

Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression.

A M Myint1, Y K Kim.   

Abstract

There are different theories and hypotheses related to the aetiology of depression. The interaction between brain 5-HT level and the activity of its autoreceptors plays a role in mood changes and depression. In major depression, activation of the inflammatory response system (IRS) and, increased concentrations of proinflammatory cytokines, prostaglandin E2 and negative immuno-regulatory cytokines in peripheral blood have been reported. Recently, pro-inflammatory cytokines have been found to have profound effects on the metabolism of brain serotonin through the enzyme indoleamine-2,3-dioxygenase (IDO) that metabolizes the tryptophan, the precursor of 5-HT to neurodegenerative quinolinate and neuroprotective kynurenate. The cytokine-serotonin interaction that leads to the challenge between quinolinate and kynurenate in the brain explains the neurodegeneration hypothesis of depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592780     DOI: 10.1016/s0306-9877(03)00207-x

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  102 in total

1.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

2.  The concept of depression as a dysfunction of the immune system.

Authors:  Brian E Leonard
Journal:  Curr Immunol Rev       Date:  2010-08

3.  Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression?

Authors:  Annie Pierre Jonville-Bera; Jean-Louis Guilmot; Gilles Aspe; Elisabeth Autret-Leca; Julie Magnant
Journal:  Eur J Clin Pharmacol       Date:  2010-10-13       Impact factor: 2.953

4.  Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.

Authors:  I Ertenli; S Ozer; S Kiraz; S B Apras; A Akdogan; O Karadag; M Calguneri; U Kalyoncu
Journal:  Rheumatol Int       Date:  2010-11-16       Impact factor: 2.631

5.  Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Lucian Del Fabbro; André Tiago Rossito Goes; Franciele Donato; Silvana Peterini Boeira
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

6.  Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect.

Authors:  Denise Janicki-Deverts; Sheldon Cohen; William J Doyle; Ronald B Turner; John J Treanor
Journal:  Brain Behav Immun       Date:  2006-10-18       Impact factor: 7.217

7.  The biology of aging and frailty.

Authors:  Neal S Fedarko
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 8.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

Review 9.  How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.

Authors:  Cynthia L Bethea; Arubala P Reddy; Fernanda Lima Christian
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  An Association Between the Inflammatory Biomarker GlycA and Depressive Symptom Severity.

Authors:  Samara Huckvale; Stephanie Reyes; Alexandra Kulikova; Anand Rohatgi; Kayla A Riggs; E Sherwood Brown
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.